Ginkgo Bioworks Holdings, Inc. (DNA)
XMEX 
NYSE Primary XMEX Summary
DNA Chart
FTAI Aviation: Innovation Is Their DNA
FTAI Aviation is innovatively leveraging jet engine cores to address the urgent power needs of data centers amid an energy bottleneck. FTAI's new power segment, repurposing CFM56 engines, could add 30% to company value by 2027, with significant upside if unit deliveries meet targets. The stock is rated Buy, with a $393 price target (57% upside) based on 25 power units sold in 2027; risk increases as FTAI enters the energy sector.
Ginkgo Bioworks Q1 Earnings Call Highlights
Ginkgo Bioworks NYSE: DNA said it is sharpening its 2026 focus on autonomous laboratories after completing the divestiture of its biosecurity business and reporting lower year-over-year cash burn in the first quarter.
TelevisaUnivision Bets Its Telenovela DNA Can Win The Microdrama Race
TelevisaUnivision is moving aggressively to turn its microdrama platform into a new growth engine, betting that the melodramatic storytelling that powered decades of telenovelas can be reshaped for mobile-first audiences in one- to two-minute vertical episodes.
Ginkgo Bioworks Holdings, Inc. (DNA) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Ginkgo Bioworks Holdings, Inc. ever had a stock split?
Ginkgo Bioworks Holdings, Inc. Profile
| Biotechnology Industry | Healthcare Sector | Jason Kelly CEO | XMEX Exchange | US37611X2099 ISIN |
| US Country | 834 Employees | - Last Dividend | 20 Aug 2024 Last Split | 19 Apr 2021 IPO Date |
Overview
Ginkgo Bioworks Holdings, Inc., operational since 2008 and based in Boston, Massachusetts, specializes in the advanced sector of cell programming within the United States. This revolutionary company has built a platform that leverages the capabilities of biology for the development and production of products that span across various industries. By harnessing the power of cell programming, Ginkgo Bioworks aims to transition the production of a vast range of products towards more sustainable and biologically driven processes. The company's efforts are pivotal in paving the way for innovations in multiple sectors, including pharmaceuticals, agriculture, industrial chemicals, food, and nutrition, showcasing the versatility and potential of biotechnology.
Products and Services
- Novel Therapeutics
Ginkgo Bioworks employs its cell programming platform to advance the field of medicine by developing novel therapeutics. This includes drugs and treatments that are based on the manipulation of biological systems, aiming to offer more effective and personalized healthcare solutions.
- Food Ingredients
By programming cells to produce specific compounds, Ginkgo Bioworks is able to create innovative food ingredients. This can lead to healthier, more sustainable, and potentially cheaper alternatives to traditional ingredients, marking a significant advance in the food and nutrition industry.
- Chemicals Derived from Petroleum
The company also focuses on the biosynthesis of chemicals that are traditionally derived from petroleum, offering a more sustainable pathway to produce these essential compounds. This approach not only helps in reducing the environmental impact but also in creating materials with potentially enhanced properties.
- Pharma and Biotech Applications
Ginkgo Bioworks serves the pharmaceutical and biotechnology sectors by providing solutions that speed up drug discovery processes, improve the efficacy of existing therapies, and contribute to the development of new treatment modalities.
- Agriculture
In agriculture, the company's technologies are used to enhance crop yield, optimize the nutritional value of food products, and create more resilient agricultural systems against climate change and pests.
- Industrial and Environmental Solutions
Ginkgo Bioworks is also at the forefront of developing biotechnological solutions for environmental and industrial challenges, including pollution control, waste reduction, and the creation of renewable energy sources.
- Consumer and Technology Products
The company influences the consumer goods and technology sector by integrating biologically engineered solutions into everyday products, thereby improving quality, sustainability, and functionality.
- Government and Defense
Lastly, Ginkgo Bioworks collaborates with government and defense industries to develop biosecurity and health monitoring systems, showcasing the critical role of biotechnology in national security and public health.
